Drug Price Trends for STROMECTOL

Average Pharmacy Cost for STROMECTOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
STROMECTOL 3 MG TABLET	00006-0032-20	4.43250	EACH	2025-01-22
STROMECTOL 3 MG TABLET	00006-0032-20	4.43250	EACH	2024-12-18

Market Analysis and Price Projections for Stromectol (Ivermectin)

Market Overview

The global ivermectin market, which includes the brand name Stromectol, is experiencing significant growth driven by several key factors. As of 2022, the global ivermectin market was valued at approximately USD 293.95 million and is projected to reach USD 398.46 million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.2% during the forecast period[3].

Market Drivers

Several factors are driving the growth of the ivermectin market:

• Increase in Parasitic Infections: The rise in prevalence of parasitic infections such as ascariasis, lymphatic filariasis, and river blindness in animals is a major driver. For instance, the prevalence of roundworms in dogs ranged from 1.8% to 5.0% in 2019, and hookworm infections were estimated to be around 2.5% to 4.5%[3].
• Technological Advancements: Advances in veterinary medicine and the increasing awareness about animal health are also contributing to the market growth[1].
• Antiviral Potential: Ivermectin has shown antiviral potential, including against the SARS-CoV-2 virus, although more clinical trials are needed to confirm its efficacy[3].

Key Players

The ivermectin market is dominated by several key players:

• MERCK: Known for its brand name Stromectol, MERCK holds a significant share of the market, with a 38.75% share in 2020[3].
• Hovione: A major player in the pharmaceutical industry, Hovione is involved in the production and distribution of ivermectin[1][3].
• Zhejiang Hisun Pharmaceutical: Another prominent player, this company contributes significantly to the global supply of ivermectin[1][3].
• Shandong Qilu King-Phar Pharmaceutical: This company is also a key player in the ivermectin market, particularly in the Asian region[1][3].
• Dr. Reddy's Laboratories: Recently, Dr. Reddy's launched a generic version of ivermectin tablets in the US market, expanding the competitive landscape[4].

Market Segmentation

The ivermectin market is segmented based on type and application:

• By Type: The market is primarily split into solid and liquid forms, with the liquid segment accounting for the largest share in 2021[3].
• By Application: The market is segmented by application into cow, sheep, pig, poultry, and others, with the cow segment occupying the biggest share from 2017 to 2022[3].

Geographical Analysis

The global ivermectin market is analyzed across various regions:

• North America: Includes the United States and Canada, with significant market presence due to high awareness and advanced veterinary care[3].
• Europe: Countries such as Germany, the UK, France, and Italy contribute to the market growth[3].
• Asia Pacific: This region, including China, Japan, and India, is expected to see substantial growth due to increasing demand for veterinary care[3].
• Latin America and Middle East & Africa: These regions also show potential for growth driven by the need for effective antiparasitic treatments[3].

Price Analysis

The pricing of ivermectin, including the brand name Stromectol, varies based on several factors such as location, pharmacy, and availability of generic versions.

• Retail Price: The average U.S. retail price for generic ivermectin tablets is around $45 for eight tablets, or approximately $5.63 per tablet[2].
• Brand Name: Stromectol tablets cost around $107 for a supply of 20 tablets, which translates to about $5.37 per tablet[5].
• Generic Versions: Generic ivermectin tablets are available at a lower cost, starting from $93.97 for 20 tablets[5].
• Discounts and Savings: Using discount cards or purchasing from accredited international pharmacies can result in significant savings, up to 80% off the retail price[2][5].

Price Projections

Given the projected market growth, here are some key price projections:

• Market Size: The global ivermectin market is expected to grow from USD 293.95 million in 2022 to USD 398.46 million by 2028, and further to USD 0.49 billion by 2032[1][3].
• CAGR: The market is expected to exhibit a CAGR of 5.2% during the forecast period[1][3].
• Price Stability: While the market size is expected to grow, the prices of ivermectin tablets are likely to remain competitive due to the presence of generic versions and discounts offered through various programs[2][5].

Challenges and Constraints

Despite the growth potential, the ivermectin market faces some challenges:

• Environmental Impact: The use of ivermectin in aquaculture has raised concerns about its toxicity to aquatic organisms, which may limit its application in certain sectors[3].
• Regulatory Approvals: The antiviral potential of ivermectin, while promising, requires further clinical trials and regulatory approvals to be fully realized[3].

Key Takeaways

• The global ivermectin market is growing due to increasing parasitic infections and technological advancements.
• Key players like MERCK, Hovione, and Dr. Reddy's Laboratories dominate the market.
• The market is segmented by type and application, with liquid forms and cow applications being the largest segments.
• Geographically, North America, Europe, and Asia Pacific are significant markets.
• Prices vary between brand and generic versions, with discounts available through various programs.
• The market is expected to grow at a CAGR of 5.2% during the forecast period.

FAQs

1. What is the current market size of the global ivermectin market? The global ivermectin market was valued at approximately USD 293.95 million in 2022[3].

2. What is the projected market size of the global ivermectin market by 2032? The global ivermectin market is expected to reach USD 0.49 billion by 2032[1].

3. What is the average retail price of generic ivermectin tablets in the US? The average U.S. retail price for generic ivermectin tablets is around $45 for eight tablets[2].

4. Which companies are the key players in the ivermectin market? Key players include MERCK, Hovione, Zhejiang Hisun Pharmaceutical, Shandong Qilu King-Phar Pharmaceutical, and Dr. Reddy's Laboratories[1][3][4].

5. What are the main drivers of the ivermectin market growth? The main drivers include the rise in parasitic infections, technological advancements, and the antiviral potential of ivermectin[1][3].

Cited Sources:

1. Business Research Insights: Ivermectin Market Size, Share, Growth, Trends, Report, 2032.
2. PharmacyChecker: How much does ivermectin cost? Can we expect shortages due to coronavirus?
3. Market Research: Global Ivermectin Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029.
4. Stock Titan: Dr. Reddy's Launches Ivermectin Generic in $20M US Market.
5. Drugs.com: Stromectol Prices, Coupons, Copay Cards & Patient Assistance.